Corona Virus: A Review of COVID-19
Corona virus causes respiratory infection including pneumonia, cold, sneezing and coughing while in animal it causes diarrhea and upper respiratory diseases. Corona virus transmitted human to human or human to animal via airborne droplets. Corona virus enters in human cell through membrane ACE-2 exopeptidase receptor. WHO and ECDC advised to avoid public place and close contact to infected persons and pet animals. Firstly Corona virus (2019-nCoV) was isolated from Wuhan market China at 7 Jan. 2020.
1.Centers for Disease Control and Prevention (CDC). Update: Outbreak of severe acute respiratory syndrome--worldwide, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(12):241–6.
2. World Health Organization. Coronavirus never before seen in humans is the cause of SARS– update 31. Geneva: The Organization; 2003.
3. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available at http://www.who.int/csr/sars/country/table2004_04_21/en/index.html. Accessed 14 feb 2020.
4. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–25. [CrossRef]
5. World Health Organization. WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China Geneva 2020 [updated 9 January 2020 and 14 January 2020]. Available from: https://www.who.int/china/news/detail/09-01-2020-whostatement-regarding-cluster-of-pneumoniacases-in-wuhanchina.
6. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. 24 January 2020. New England Journal of Medicine. [CrossRef]
7. Mailles A, Blanckaert K, Chaud P, van der Werf S, Lina B, Caro V, et al. First cases of Middle East respiratory syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, Euro Surveill. 2013;18:20502.
8. Buchholz U, Müller MA, Nitsche A, Sanewski A, Wevering N, Bauer-Balci T, et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 2013;18:20406.
9. Saif LJ. Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? Rev Sci Tech. 2004;23:643–60. [CrossRef]
10. Gwaltney JM Jr. Virology and immunology of the common cold. Rhinology. 1985;23:265.
11. Tyrrell DAJ, Myint SH. Chapter 60: Coronaviruses. In Barson 1 S, editor. Medical microbiology. 4th edition. Galveston: University of Texas Medical Branch at Galveston; 1996.
12. Woo PC, Lau SK, Huang Y, Yuen KY. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood). 2009;234:1117–27. [CrossRef]
13. de Souza Luna LK, Heiser V, Regamey N, Panning M, Drexler JF, Mulangu S, et al. Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription–PCR and nonfluorescent low-density microarray. J Clin Microbiol. 2007;45:1049–52. [CrossRef]
14. Letko M, Munster V. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019- nCoV. bioRxiv. 22 January 2020. 915660. [CrossRef]
15. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. 24 January 2020. New England Journal of Medicine. [CrossRef]
16. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 24 January 2020. [CrossRef]
17. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 24 January 2020. [CrossRef]
18. European Centre for Disease Prevention and Control (ECDC). Case definition and European surveillance for human infection with novel coronavirus (2019-nCoV) [14 feb 2020]. Available from: https://www.ecdc.europa.eu/en/case-definition-and-european-surveillance-human-infection-novelcoronavirus-2019-ncov
19. European Centre for Disease Prevention and Control (ECDC). Health emergency preparedness for imported cases of highconsequence infectious diseases 2019 [14 feb 2020]. Available from: https://www.ecdc.europa.eu/en/publications-data/ health-emergency-preparedness-imported-cases-highconsequence-infectious-diseases
20. Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52:715–20. [CrossRef]
21. Chan JF, Chan KH, Kao RY, To KK, Zheng BJ, Li CP, et al. Broadspectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Inf Secur. 2013;67:606–16. [CrossRef]
22. Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014;20:42–6. [CrossRef]
23. Al-Qahtani AA, Lyroni K, Aznaourova M, Tseliou M, Al-Anazi MR, Al-Ahdal MN, et al. Middle East respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ. Oncotarget. 2017;8(6):9053–66. doi:10.18632/oncotarget.14754.
24. Bin Saeed AA, Abedi GR, Alzahrani AG, Salameh I, Abdirizak F, Alhakeem R, et al. Surveillance and testing for Middle East respiratory syndrome Coronavirus, Saudi Arabia, April 2015–February 2016. Emerg Infect Dis. 2017;23(4):682–5. doi:10.3201/eid2304.161793. [CrossRef]
25. Arabi YM, Balkhy HH, Hayden FG, Bouchama A, Luke T, Baillie JK, et al. Middle East respiratory syndrome. N Engl J Med. 2017;376(6):584–94. doi:10.1056/NEJMsr1408795. [CrossRef]
26. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov. pdf?sfvrsn=20a99c10_4 accessed at 18/02/2020
27. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200122-sitrep-2-2019-ncov. pdf?sfvrsn=4d5bcbca_2 accessed at 18/02/2020
28. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200123-sitrep-3-2019-ncov. pdf?sfvrsn=d6d23643_8 accessed at 18/02/2020
29. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200124-sitrep-4-2019-ncov. pdf?sfvrsn=9272d086_8 accessed at 18/02/2020
30. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200125-sitrep-5-2019-ncov. pdf?sfvrsn=429b143d_8 accessed at 18/02/2020
31. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200126-sitrep-6-2019--ncov. pdf?sfvrsn=beaeee0c_4 accessed at 18/02/2020
32. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov. pdf?sfvrsn=98ef79f5_2 accessed at 18/02/2020
33. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200128-sitrep-8-ncov-cleared. pdf?sfvrsn=8b671ce5_2 accessed at 18/02/2020
34. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200129-sitrep-9-ncov-v2. pdf?sfvrsn=e2c8915_2 accessed at 18/02/2020
35. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov. pdf?sfvrsn=d0b2e480_2 accessed at 18/02/2020
36. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200131-sitrep-11-ncov. pdf?sfvrsn=de7c0f7_4 accessed at 18/02/2020
37. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200201-sitrep-12-ncov. pdf?sfvrsn=273c5d35_2 accessed at 18/02/2020
38. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200202-sitrep-13-ncov-v3. pdf?sfvrsn=195f4010_6 accessed at 18/02/2020
39. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200203-sitrep-14-ncov. pdf?sfvrsn=f7347413_4 accessed at 18/02/2020
40. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200204-sitrep-15-ncov. pdf?sfvrsn=88fe8ad6_4 accessed at 18/02/2020
41. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200205-sitrep-16-ncov. pdf?sfvrsn=23af287f_4 accessed at 18/02/2020 [CrossRef]
42. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200206-sitrep-17-ncov. pdf?sfvrsn=17f0dca_4 accessed at 18/02/2020
43. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200207-sitrep-18-ncov. pdf?sfvrsn=fa644293_2 accessed at 18/02/2020
44. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200208-sitrep-19-ncov. pdf?sfvrsn=6e091ce6_4 accessed at 18/02/2020
45. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200209-sitrep-20-ncov. pdf?sfvrsn=6f80d1b9_4 accessed at 18/02/2020
46. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200210-sitrep-21-ncov. pdf?sfvrsn=947679ef_2 accessed at 18/02/2020 [CrossRef]
47. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov. pdf?sfvrsn=fb6d49b1_2 accessed at 18/02/2020
48. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2 accessed at 18/02/2020
49. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200213-sitrep-24-covid-19. pdf?sfvrsn=9a7406a4_4 accessed at 18/02/2020
50. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200214-sitrep-25-covid-19. pdf?sfvrsn=61dda7d_2 accessed at 18/02/2020
51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200215-sitrep-26-covid-19. pdf?sfvrsn=a4cc6787_2 accessed at 18/02/2020
52. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200216-sitrep-27-covid-19. pdf?sfvrsn=78c0eb78_2 accessed at 18/02/2020
53. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200217-sitrep-28-covid-19. pdf?sfvrsn=a19cf2ad_2 accessed at 18/02/2020
54. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200218-sitrep-29-covid-19. pdf?sfvrsn=6262de9e_2 accessed at 19/02/2020